InduPro
Develops proximity-guided antibody-drug conjugate therapeutics for cancer and autoimmune disease
$77MSeries B
Role not disclosedTC
The Column Group
Activity from announced rounds
Activity in this selectionSeries B
The Column Group is the investment firm named in InduPro and Circle Pharma financing histories.
Recorded funding activity
InduPro develops proximity-guided antibody-drug conjugates. Circle develops macrocycle medicines. The investor’s identity is preserved without equating unrelated TCG-labeled vehicles.
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $77M 1 disclosed · full round size, not this investor’s share